Use of ginsenoside Rg2 in preparing medicine for treating myelosuppression and medicine containing ginsenoside Rg2

Abstract

The invention discloses use of ginsenoside Rg2 in preparing a medicine for treating myelosuppression and a medicine containing the ginsenoside Rg2, and belongs to the technical field of medicines. The invention provides novel use of the ginsenoside Rg2 in resisting myelosuppression. When myelosuppression is caused by chemotherapy, the ginsenoside Rg2 can promote bone marrow cell component recovery, increases the bone marrow nucleated cell number, remarkably improves the number of bone marrow granulocyte-mononuclear and pre-B colony forming units, promotes proliferation of granulocyte-mononuclear and pre-B hematopoietic progenitor cells, and thus has an effect of promoting bone marrow hematopoiesis.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to the application of ginsenoside Rg2 in the preparation of medicines for treating myelosuppression and medicines containing ginsenoside Rg2. Background technique [0002] Ginseng belongs to the family Araliaceae and is a perennial herb. It has been known as the "King of Herbs" since ancient times. It is usually used as medicine with dried roots and rhizomes. It tastes sweet, slightly bitter, and warm and flat. Ginseng has the effects of "mainly nourishing the five internal organs, calming the spirit, calming the soul, relieving palpitations, eliminating evil spirits, improving eyesight, improving intelligence, and long-term use to lighten the body and prolong life". Ginsenosides are considered to be the main active ingredients in ginseng, including RH2, Rg1, Rg2, Rg3, etc., and their main functions are anti-tumor, enhancing the body's anti-oxidation and anti-aging cap...

AI Technical Summary

Problems solved by technology

However, there is no clear report on its efficacy and mechanism of action in anti-myelosuppression.

Images